[et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Sezione” _builder_version=”4.16″ height=”400px” custom_margin=”0px|0px|0px|0px|false|false” custom_padding=”0px|0px||0px|false|false” bottom_divider_style=”slant2″ bottom_divider_color=”#ffffff” global_colors_info=”{}”][et_pb_fullwidth_post_title title=”off” meta=”off” featured_placement=”background” _builder_version=”4.16″ title_font=”|600|||||||” title_text_align=”left” use_background_color_gradient=”on” background_color_gradient_stops=”rgba(255,255,255,0) 0%|#ffffff 100%” background_color_gradient_start=”rgba(255,255,255,0)” background_color_gradient_end=”#ffffff” parallax=”on” parallax_method=”off” custom_margin=”0px|0px|0px|0px|false|false” custom_padding=”0px|0px|0px|0px|false|false” global_colors_info=”{}”][\/et_pb_fullwidth_post_title][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ custom_padding=”100px|0px|0px|0px|false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.16″ text_font_size=”16px” header_font=”|600|||||||” header_text_align=”left” header_font_size=”32px” header_2_text_align=”left” background_size=”initial” background_position=”top_left” background_repeat=”repeat” header_text_align_tablet=”” header_text_align_phone=”” header_text_align_last_edited=”on|desktop” global_colors_info=”{}”]<\/p>\n
Innovator in bone density diagnostic technology brings expertise to foundation.<\/strong><\/p>\n SEATTLE<\/span>,\u00a0Feb. 23, 2021<\/span>\u00a0\/PRNewswire\/ —\u00a0Echolight Medical<\/a>, manufacturer of the radiation-free\u00a0EchoS<\/b>\u00a0portable densitometer, has joined the\u00a0National Osteoporosis Foundation<\/a>\u00a0(NOF) Corporate Advisory Roundtable<\/b>. Focusing on bone health and patient access, NOF’s corporate roundtable advises the board of trustees and develops initiatives to address\u00a0“the fundamental forces affecting the public’s access to osteoporosis information and medical care.”<\/i><\/p>\n “We are pleased to contribute to this influential group and be in a position to truly have an impact,” said\u00a0Doug Tefft<\/span><\/a>, president of Echolight\u00a0USA<\/span>\u00a0(launched\u00a0September 2020<\/span>). “It’s a privilege to join this group of accomplished leaders working across the osteoporosis field – we firmly believe these partnerships and shared passions will expand health care access to many more people.”<\/p>\n EchoS<\/a>, widely used throughout\u00a0Europe<\/span>, is the first radiation-free, portable bone densitometer used to regularly monitor key bone health indicators. Using\u00a0Radiofrequency Echographic Multi Spectrometry<\/a>\u00a0(REMS<\/b>) to analyze ultrasound signals, patients know their bone health scores and future fracture risk within minutes. REMS is more cost-efficient, accessible, and accurate than the current bone mineral density measurement technology, DXA.\u00a0<\/p>\n “It’s important to have innovative companies and technologies included in our discussions to help bring about better outcomes for patients,”\u00a0said\u00a0Claire Gill<\/span>, CEO of the\u00a0<\/i>National Osteoporosis Foundation<\/b>. “We look forward to working with\u00a0Echolight on efforts to substantially increase osteoporosis screenings in the U.S.”<\/p>\n More than half of Americans age 50 and older have a high-risk of bone fracture, making\u00a0osteoporosis<\/b>\u00a0and\u00a0osteopenia<\/b>\u00a0an urgent public health issue. It is especially prominent in women, as pregnancy and menopause can cause bone density loss. Chronic conditions such as diabetes, rheumatoid arthritis, kidney or liver disease, cancer, HIV and lupus, and medications to treat these and other ailments also cause increased risk of fracture.\u00a0More women die annually from the effects of osteoporosis than breast and cervical cancer combined<\/b>. REMS can help in early and accurate diagnosis to make informed bone health decisions and enhance quality of life.<\/p>\n For more information:<\/p>\n